Know Your Risk for Cognitive Decline
What is a Cognoscopy?
A cognoscopy is a term coined by Dr. Bredesen, that refers to a simple assessment, which uses a combination of laboratory and cognitive testing that identifies the contributors to cognitive decline or risk for decline. We all know that, when we turn 50 years old, we should have a colonoscopy, so that we can detect and treat colon cancer early, thus avoiding advanced, life-threatening cancer. But what about our brains? Just as with colon cancer, the pathology behind neurodegeneration, including Alzheimer’s, takes many years — often decades — to develop, providing for an extended prodromal period in which we can effectively intervene. The good news is that we can now check our risk and intervene as early as possible to identify if we have emerging contributors that are silently contributing to neurodegenerative pathology. We can do this by following three simple steps.
Three Simple Steps for Assessing Cognitive Risk
- A set of blood tests that reveals risk factors for dementia.
- A series of simple, on-line cognitive assessments that indicate whether there are any areas of concern currently.
- An MRI scan with volumetrics. The MRI is optional for those who have no symptoms but is recommended for those who already have cognitive symptoms or whose cognitive scores suggest any degree of cognitive impairment.
How Much Does a Cognoscopy Cost?
The price of a cognoscopy is included in the cost of the PreCODE or ReCODE Program™.
Get Your Cognoscopy Today
You can easily access a cognoscopy through either our PreCODE or ReCODE Programs. Which program is right for you?
- PreCODE is the only clinically proven program to optimize brain health and prevent cognitive decline.
To assess your risk, we collect your health history through a medical questionnaire, laboratory testing, and cognitive testing. See the PreCODE Test Panel for more information on testing in PreCODE.
These data are run through a software algorithm that will identify any emerging contributors to cognitive decline. Once analyzed, you’ll receive a detailed report with a comprehensive treatment plan to ensure healthy cognition for years to come. Check out a sample report generated from PreCODE testing.
- ReCODE is the only clinically proven program to reverse cognitive decline in early-stage Alzheimer’s disease.
To determine which factors are impacting your cognition and to assess your risk of further decline, we collect your health history through a medical questionnaire, laboratory testing, and cognitive testing. See the ReCODE Test Panel for information on testing in ReCODE.
These data are run through a software algorithm that will specifically identify what is contributing to your current state of cognition. Once analyzed, you’ll receive a detailed report with a comprehensive treatment plan to help you optimize your cognition for years to come. Check out a sample report generated from ReCODE testing.